Clinical Trial

PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study)

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn about Phase I+Phase II Clinical Study of PRaG Therapy in Combination With Chemotherapy (AG Regimen) for Neoadjuvant Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study).The main question it aims to answer is to investigate the safety and efficacy of the PRaG treatment modality combined with chemotherapy neoadjuvant therapy for locally advanced pancreatic cancer.
Trial Details
NCT Number NCT06345599
Lead Sponsor Second Affiliated Hospital of Soochow University
Conditions Pancreatic Ductal Adenocarcinoma
Enrollment 66 participants
Start Date 2024-05-01
Primary Completion 2027-01-10 (estimated)
Study Completion 2027-01-10 (estimated)
Updated on ClinicalTrials.gov 2024-04-03